186 related articles for article (PubMed ID: 37530790)
21. Diagnostic Utility of Flow Cytometry Analysis of Reactive T Cells in Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
David JA; Huang JZ
Am J Clin Pathol; 2016 Jan; 145(1):107-15. PubMed ID: 26712878
[TBL] [Abstract][Full Text] [Related]
22. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
23. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
Tian X; Xu J; Dorfman DM
Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
[TBL] [Abstract][Full Text] [Related]
24. Nodular lymphocyte predominant Hodgkin lymphoma: diagnostic pearls and pitfalls.
Smith LB
Arch Pathol Lab Med; 2010 Oct; 134(10):1434-9. PubMed ID: 20923296
[TBL] [Abstract][Full Text] [Related]
25. Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
Gibson SE; Dojcinov S; Dotlic S; Hartmann S; Hsi ED; Klimkowska M; Melle F; Pileri SA; Ramsower CA; Rech K; Rimsza LM; Rodriguez-Pinilla SM; Tousseyn TA; de Jong D; Sabattini E
Virchows Arch; 2023 Dec; 483(6):733-749. PubMed ID: 37530791
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting.
Glynn E; Fromm JR
Cytometry B Clin Cytom; 2020 Jan; 98(1):88-98. PubMed ID: 31254446
[TBL] [Abstract][Full Text] [Related]
27. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.
Tousseyn TA; King RL; Fend F; Feldman AL; Brousset P; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):207-226. PubMed ID: 36274093
[TBL] [Abstract][Full Text] [Related]
28. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.
Van Loo P; Tousseyn T; Vanhentenrijk V; Dierickx D; Malecka A; Vanden Bempt I; Verhoef G; Delabie J; Marynen P; Matthys P; De Wolf-Peeters C
Haematologica; 2010 Mar; 95(3):440-8. PubMed ID: 19797726
[TBL] [Abstract][Full Text] [Related]
29. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
30. Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.
Sohani AR; Jaffe ES; Harris NL; Ferry JA; Pittaluga S; Hasserjian RP
Am J Surg Pathol; 2011 Nov; 35(11):1666-78. PubMed ID: 21997687
[TBL] [Abstract][Full Text] [Related]
31. Predominance of CD4+ T Cells in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma and Identification of a Subset of Patients With Peripheral B-Cell Lymphopenia.
Kunder C; Cascio MJ; Bakke A; Venkataraman G; O'Malley DP; Ohgami RS
Am J Clin Pathol; 2017 Jun; 147(6):596-603. PubMed ID: 28575178
[TBL] [Abstract][Full Text] [Related]
32. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
[TBL] [Abstract][Full Text] [Related]
33. A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediastinal large B cell lymphoma.
Martig DS; Fromm JR
Cytometry B Clin Cytom; 2022 Jan; 102(1):14-25. PubMed ID: 34878224
[TBL] [Abstract][Full Text] [Related]
34. Flow Cytometric Detection of the Double-Positive (CD4+CD8+)/PD-1bright T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Chen ZW; Wizniak J; Shang C; Lai R
Arch Pathol Lab Med; 2022 Jun; 146(6):718-726. PubMed ID: 34506624
[TBL] [Abstract][Full Text] [Related]
35. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
[TBL] [Abstract][Full Text] [Related]
36. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
37. Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D.
El Hussein S; Wang X; Fang H; Jelloul FZ; Wang W; Loghavi S; Vega F; Miranda RN; Muzzafar T; Manning JT; Khoury JD; Burack WR; Evans AG; Medeiros LJ
Am J Surg Pathol; 2022 Sep; 46(9):1291-1297. PubMed ID: 35575765
[TBL] [Abstract][Full Text] [Related]
38. Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyte-rich large B-cell lymphoma and lymphocyte-predominant Hodgkin lymphoma.
Mourad WA; Al Thani S; Tbakhi A; Al Omari M; Khafaga Y; Shoukri M; El Weshi A; Al Shabana M; Ezzat A
Hematol Oncol Stem Cell Ther; 2008; 1(1):22-7. PubMed ID: 20063524
[TBL] [Abstract][Full Text] [Related]
39. Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
Fan Z; Natkunam Y; Bair E; Tibshirani R; Warnke RA
Am J Surg Pathol; 2003 Oct; 27(10):1346-56. PubMed ID: 14508396
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base.
Ollila TA; Reagan JL; Olszewski AJ
Leuk Lymphoma; 2019 Dec; 60(14):3426-3433. PubMed ID: 31287335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
